US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Altimmune, Inc. - Common Stock
(NQ:
ALT
)
2.670
-0.065 (-2.38%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Altimmune, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - ALT
September 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
September 18, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday
↗
September 18, 2025
Via
Benzinga
Shareholders That Lost Money on Altimmune, Inc. (ALT) Should Contact Levi & Korsinsky About Pending Class Action - ALT
September 18, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Shareholders That Lost Money on Altimmune, Inc. (ALT) Should Contact Levi & Korsinsky About Pending Class Action - ALT
September 18, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune
September 17, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
October 6, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
September 17, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
October 6, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
September 17, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
October 6, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
September 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
October 6, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against ALT
September 16, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Shareholders That Lost Money on Altimmune, Inc. (ALT) Should Contact Levi & Korsinsky About Pending Class Action - ALT
September 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Shareholders That Lost Money on Altimmune, Inc. (ALT) Should Contact Levi & Korsinsky About Pending Class Action - ALT
September 15, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune and SelectQuote that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
September 15, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
September 14, 2025
From
Pomerantz LLP
Via
GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALT
September 12, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
Class Action Filed Against Altimmune, Inc. (ALT) - October 6, 2025 Deadline to Join - Contact Levi & Korsinsky
September 12, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Class Action Filed Against Altimmune, Inc. (ALT) - October 6, 2025 Deadline to Join - Contact Levi & Korsinsky
September 12, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Faruqi & Faruqi Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025 - ALT
September 11, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Class Action Filed Against Altimmune, Inc. (ALT) Seeking Recovery for Investors - Contact Levi & Korsinsky
September 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Class Action Filed Against Altimmune, Inc. (ALT) Seeking Recovery for Investors - Contact Levi & Korsinsky
September 11, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
September 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALT
September 10, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Levi & Korsinsky Reminds Altimmune, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
September 10, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Reminds Altimmune, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
September 10, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
September 09, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 6, 2025 - ALT
September 09, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Important Notice to Long-Term Shareholders of Altimmune, Inc. (NASDAQ: ALT); Digimarc Corporation (NASDAQ: DMRC); Nutex Health Inc. (NASDAQ: NUTX); and Quantum Corporation (NASDAQ: QMCO): Grabar Law Office is Investigating Claims on Your Behalf
September 08, 2025
From
Grabar Law Office
Via
GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Altimmune, Inc. (ALT) of a Class Action Lawsuit and an Upcoming Deadline
September 08, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Fraud
Lawsuit
Levi & Korsinsky Notifies Shareholders of Altimmune, Inc. (ALT) of a Class Action Lawsuit and an Upcoming Deadline
September 08, 2025
Via
TheNewswire.com
Topics
Fraud
Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm
September 07, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
